Searches both Title and Fulltext content
Takes you to the requested Key Event
Clear Search Terms Clears search terms and filters

Showing 1476 to 1500 of 1959 Key Events

Clear Table Filters
ID Title Event Component Count Biological Organization Created At Last Updated AOPs
868 Increase, Tissue Degeneration, Necrosis & Atrophy
2 Tissue Nov 29, 2016 Sep 16, 2017 136: Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors
867 Decrease, Intracellular pH
1 Cellular Nov 29, 2016 Sep 16, 2017 136: Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors
864 Decreased, Body Weight
1 Individual Nov 29, 2016 Apr 30, 2019 6: Antagonist binding to PPARα leading to body-weight loss
863 Increased, Catabolism of Muscle Protein
1 Organ Nov 29, 2016 Apr 30, 2019 6: Antagonist binding to PPARα leading to body-weight loss
862 Not Increased, Circulating Ketone Bodies
2 Tissue Nov 29, 2016 Apr 30, 2019 6: Antagonist binding to PPARα leading to body-weight loss
861 Decreased, Ketogenesis (production of ketone bodies)
1 Cellular Nov 29, 2016 Apr 30, 2019 6: Antagonist binding to PPARα leading to body-weight loss
860 Decreased, Mitochondrial Fatty Acid Beta Oxidation
1 Molecular Nov 29, 2016 Sep 16, 2017 318: Glucocorticoid Receptor activation leading to hepatic steatosis
859 Decreased, Peroxisomal Fatty Acid Beta Oxidation of Fatty Acids
1 Molecular Nov 29, 2016 Sep 16, 2017 None
858 Decreased, PPARalpha transactivation of gene expression
1 Molecular Nov 29, 2016 Apr 30, 2019 6: Antagonist binding to PPARα leading to body-weight loss
857 Binding as antagonist, Antagonist binding to PPARalpha ligand binding domain
0 Molecular Nov 29, 2016 Nov 29, 2016 None
856 Formation, Hepatocellular and Bile duct tumors
2 Organ Nov 29, 2016 Sep 16, 2017 41: Sustained AhR Activation leading to Rodent Liver Tumours
854 Alterations, Cellular proliferation / hyperplasia
3 Tissue Nov 29, 2016 Sep 16, 2017
853 Changes/Inhibition, Cellular Homeostasis and Apoptosis
2 Cellular Nov 29, 2016 Sep 16, 2017 41: Sustained AhR Activation leading to Rodent Liver Tumours
851 Decrease of GABAergic interneurons
1 Cellular Nov 29, 2016 Apr 4, 2019
850 Induction, CYP1A2/CYP1A5
2 Molecular Nov 29, 2016 May 30, 2018
849 Inhibition, Antgonism of NE receptor
1 Molecular Nov 29, 2016 Dec 3, 2016 126: Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation
848 Decreased, Binding of NE to NE receptors on GnRH neurons
1 Cellular Nov 29, 2016 Sep 16, 2017 126: Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation
846 Accumulation, Highly carboxylated porphyrins
1 Organ Nov 29, 2016 May 7, 2018 131: Aryl hydrocarbon receptor activation leading to uroporphyria
845 Inhibition, UROD
1 Molecular Nov 29, 2016 May 30, 2018 131: Aryl hydrocarbon receptor activation leading to uroporphyria
844 Oxidation, Uroporphyrinogen
1 Cellular Nov 29, 2016 Sep 16, 2017 131: Aryl hydrocarbon receptor activation leading to uroporphyria
840 Formation, Liver fibrosis
1 Tissue Nov 29, 2016 Sep 16, 2017 130: Phospholipase A2 (LPLA2) inhibitors leading to hepatotoxicity
839 Formation, Mallory body
1 Cellular Nov 29, 2016 Dec 3, 2016 130: Phospholipase A2 (LPLA2) inhibitors leading to hepatotoxicity
838 Induction, Microvesicular fat
1 Tissue Nov 29, 2016 Dec 3, 2016 130: Phospholipase A2 (LPLA2) inhibitors leading to hepatotoxicity
837 Occurrence, Cytoplasmic vacuolization (kupffer cell)
1 Cellular Nov 29, 2016 Sep 16, 2017 130: Phospholipase A2 (LPLA2) inhibitors leading to hepatotoxicity
836 Occurrence, Cytoplasmic vacuolization (Bile duct cell)
1 Cellular Nov 29, 2016 Sep 16, 2017 130: Phospholipase A2 (LPLA2) inhibitors leading to hepatotoxicity